Verotoxins induce apoptosis in human renal tubular epithelium derived cells.
Apoptosis mediated by verotoxins (VTs) has been identified in a renal carcinoma cell line, ACHN cells, which are an in vitro model of renal tubular epithelial cells. ACHN cells express the renal tubular marker CD24 as well as globotriaosyl ceramide/CD77, the receptor for VTs. VT binding to the ACHN cell surface was confirmed by positive staining with antibodies to the VTs. Treatment of ACHN cells with VTs induced prompt growth inhibition and cell death, and fragmentation of the genomic DNA in cells, typical of apoptosis, was observed. The expression of apoptotic antigen 7A6 detected by APO2.7 antibody in ACHN cells further supports the occurrence of apoptosis as a result of VT treatment. Cycloheximide enhanced VT-mediated apoptosis of ACHN cells, suggesting a strong correlation between the inhibition of protein synthesis and VT-mediated apoptosis. Moreover, tumor necrosis factor-alpha had a synergistic effect on VT-mediated apoptosis in ACHN cells. Considering the above evidence together with the clinical evidence showing the presence of apoptosis in the renal epithelium of a HUS patient, our results suggest a VT-induced apoptotic mechanism in normal renal tubular epithelium that may contribute to the pathogenesis of hemolytic uremic syndrome.
Taguchi
T
T
Department of Pathology, National Children's Medical Research Center, Tokyo, Japan.
Uchida
H
H
Kiyokawa
N
N
Mori
T
T
Sato
N
N
Horie
H
H
Takeda
T
T
Fujimoto
J
J
D000954:Antigens, Surface / Q000378:metabolism; D017209:Apoptosis / Q000502:physiology*; D001427:Bacterial Toxins / Q000378:metabolism / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D006463:Hemolytic-Uremic Syndrome / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D007668:Kidney / Q000473:pathology / Q000503:physiopathology; D007684:Kidney Tubules / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D010641:Phenotype; D022622:Shiga Toxin 1; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D000954:Antigens, Surface; D001427:Bacterial Toxins; D022622:Shiga Toxin 1; D014409:Tumor Necrosis Factor-alpha